Redeye (and the stock market) appraises that Saniona has secured SEK 80 mn in non-dilutive debt fina...
Orexo reported its Q2 numbers this morning with sales of SEK 142.
Bactiguard’s Q2 sales of SEK 46m were in line with our expectations, however, excluding a milestone payment from Zimmer Biomet (SEK 8.
Beijer Group's sales came in slightly below our estimates, while the order intake was exceptionally ...
Adjusted EBITDA 44% above ABGSCe NOK 300 in orders announced in Q2 EV/EBIT will be 11x if it reaches...
Stabilt Q2'21 Elanders levererade EBITA på 145 mkr (72), drivet av förbättringar inom såväl Supply Chain Solutions med EBITA på 127 mkr (89)...
Finnair’s Q2 losses were pretty much as expected. The company estimates Q3 operating loss will also ...
Although Q2 might not be an eventful quarter in the underlying business, the fact that it will be th...
Analysguiden återupptar bevakning av läkemedelsbolaget Calliditas Therapeutics.
Q2 ITABs omsättning under Q2'21 var 1 488 mkr (1 142 mkr i Q2'20) och EBITDA exkl.
CDON, the Nordic region's largest marketplace, reported GMV decline of 10% (but 3P +4%) in Q2 (SEBe ...
Redeye sees a soft Q2 report from Proact, showing solid cost control but decreasing Cloud revenue, h...
Svagt andra kvartal Angler har meddelat marknaden att omsättningen under Q2 kommer ligga i spannet E...
Nexam Chemical reported a solid Q2, with sales growth of 64% YOY in line with our estimate, driven by 114% growth in Performance Chemicals.
On 14 July, Sparekassen Sjælland-Fyn raised its 2021 pre-tax profit guidance range from DKK 350-425m...
Raute’s environment has improved faster than we expected, as seen in the recent signing of two large...
Sdiptech will report its Q2 results on 22 July. We expect a solid quarter with 18% y/y sales growth and 37% y/y EBITA* growth, despite meani...
Elanders presented a solid Q2 report, with its margin increasing roughly 230 bp y/y, although somewh...
Rovio's Q2 report will likely be a double-edged sword, but could be a minor positive trigger for the...
SyntheticMR’s Q2 report was a setback from previous quarters’ strong trends with results being overall weaker-than-expected.
We expect organic growth of 12%... We believe that BHG is likely to report another set of solid numb...
Redeye comments on the signing of the acquisition of Smaato that was announced today, a transformati...
Redeye revises slightly its revenue and EBITDA projections for 2021.
Konsortium lett av huvudägare bjuder 76 kr per aktie Den 7 juli offentliggjordes ett erbjudande från...
Higher costs to handle supply chain turmoil Elanders reported a mild quarter with disappointing marg...
The Thoracic business delivers CER organic growth of 82% with improved gross margins with significant US support.
Förvärvar QM Media för EUR 16m Raketech har förvärvat det svenska affiliatebolaget QM Media för EUR ...
Redeye lowers the expected GMV in Q2’21, as we have seen indications of more muted site traffic.
